查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947525

奈米机器人市场：依类型（奈米操纵器、奈米机器人系统）、应用类别（体内、体外/体外）、技术（磁驱动、生物混合推进）、应用（医疗、分子製造）和最终用户划分－全球预测至2036年

Nanorobotics Market by Type (Nano-manipulators, Nanorobotic Systems), Deployment (In-vivo, In-vitro/Ex-vivo), Technology (Magnetic Actuation, Biohybrid Propulsion), Application (Healthcare, Molecular Manufacturing), End-User- Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 288 Pages | 商品交期: 5-7个工作天内

价格
简介目录

全球奈米机器人市场预计将以14.2%的复合年增长率成长，从2026年的82.7亿美元成长到2036年的约311.9亿美元。

本报告对全球五大主要地区的奈米机器人市场进行了详细分析，重点关注当前市场趋势、市场规模、近期发展以及至2036年的预测。透过广泛的二级和一级研究以及对市场现状的深入分析，本报告对关键产业驱动因素、限制因素、机会和挑战的影响进行了分析。

推动奈米机器人市场成长的关键因素包括全球对精准医疗日益增长的兴趣以及自主分子系统的快速发展。此外，人工智慧驱动的奈米医学的整合、对即时细胞级干预需求的不断增长以及先进奈米机器人平台的扩展，预计将为该市场中的企业创造巨大的成长机会。

市场区隔

目录

第一章：引言

第二章：摘要整理

第三章：市场概览

  • 市场动态
    • 驱动因素
    • 限制因素
    • 机遇
    • 挑战
  • 市场趋势

第四章 全球奈米机器人市场（依类型划分）

  • 奈米操纵器
    • 原子力显微镜 (AFM)
    • 扫描穿隧显微镜（STMs）
    • 其他
  • 奈米机器人系统
    • 生物奈米机器人
    • 磁导奈米机器人
    • 机电奈米机器人
    • 其他
  • 软体与控制系统

第五章 全球奈米机器人市场依应用领域划分

  • 体内应用
    • 标靶药物递送
    • 外科手术
    • 诊断影像
    • 组织工程与修復
    • 其他体内应用
  • 体外/离体应用
    • 实验室研究
    • 药物发现
    • 诊断与检测
    • 其他体外应用应用

第六章 全球奈米机器人市场（依技术划分）

  • 磁力驱动
    • 电磁场系统
    • 永磁系统
    • 混合磁力系统
  • 生物混合/生物推进
    • 细胞推进
    • 生物马达系统
    • 混合生物合成系统
  • 声音/超音波推进
    • 超音波驱动
    • 声流
    • 共振系统
  • 光驱动
    • 光子推进
    • 光遗传控制
    • 电浆系统
  • 其他技术

第七章 全球奈米机器人市场（依应用领域划分）

  • 医疗
    • 药物输送
    • 诊断与影​​像
    • 奈米外科手术与组织修復
    • 牙科应用
    • 其他医疗应用
  • 分子製造
  • 研发
  • 环境监测
  • 工业与电子

第八章 全球奈米机器人市场（依最终用户划分）

  • 医院与临床中心
  • 製药与生技公司
  • 学术与研究机构
  • 医疗器材原始设备製造商 (OEM)
  • 工业製造商
  • 其他最终用户

第九章 全球奈米机器人市场依地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 瑞士
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲和纽西兰
    • 其他亚太国家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 智利
    • 哥伦比亚
    • 其他拉丁美洲国家
  • 中东和非洲
    • 海湾合作委员会国家
      • 沙乌地阿拉伯阿拉伯
      • 阿拉伯联合大公国
      • 卡达
      • 其他海湾合作委员会成员国
    • 南非
    • 以色列
    • 埃及
    • 奈及利亚
    • 其他中东和非洲国家

第十章 竞争格局

  • 主要公司策略
  • 竞争对手概览
    • 行业领导者
    • 市场差异化因素
    • 先行企业
    • 新兴企业
  • 主要公司市占率分析

第11章 企业简介

  • JEOL Ltd.(Japan)
  • Thermo Fisher Scientific Inc.(US)
  • Bruker Corporation(Germany)
  • Hitachi High-Tech Corporation(Japan)
  • ZEISS Group(Germany)
  • Oxford Instruments(UK)
  • Imina Technologies(Switzerland)
  • SmarAct GmbH(Germany)
  • Stereotaxis, Inc.(US)
  • Ginkgo Bioworks(US)
  • EV Group(Austria)

第12章 附录

简介目录
Product Code: MRHC - 1041780

Nanorobotics Market by Type (Nano-Manipulators, Nanorobotic Systems), Deployment (In-Vivo, In-Vitro/Ex-Vivo), Technology (Magnetic Actuation, Biohybrid Propulsion), Application (Healthcare, Molecular Manufacturing), End-User (Hospitals & Clinical Centers, Research Institutions, Pharmaceutical Companies), and Geography - Global Forecast to 2036

According to the research report titled, 'Nanorobotics Market by Type (Nano-Manipulators, Nanorobotic Systems), Deployment (In-Vivo, In-Vitro/Ex-Vivo), Technology (Magnetic Actuation, Biohybrid Propulsion), Application (Healthcare, Molecular Manufacturing), End-User (Hospitals & Clinical Centers, Research Institutions, Pharmaceutical Companies), and Geography - Global Forecast to 2036,' the global nanorobotics market is expected to reach approximately USD 31.19 billion by 2036 from USD 8.27 billion in 2026, at a CAGR of 14.2% during the forecast period (2026-2036).

The report provides an in-depth analysis of the global nanorobotics market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.

The major factors driving the growth of the nanorobotics market include the intensifying global focus on precision medicine and the rapid expansion of autonomous molecular systems. Additionally, the integration of AI-driven nanomedicine, increasing demand for real-time cellular-level intervention, and expansion of advanced nanorobotic platforms are expected to create significant growth opportunities for players operating in the nanorobotics market.

Market Segmentation

The nanorobotics market is segmented by type (nano-manipulators, nanorobotic systems), deployment (in-vivo, in-vitro/ex-vivo), technology (magnetic actuation, biohybrid propulsion), application (healthcare, molecular manufacturing), end-user (hospitals & clinical centers, research institutions, pharmaceutical companies), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Type

By type, the nanorobotic systems segment holds the largest market share in 2026, primarily attributed to their comprehensive functionality in supporting targeted drug delivery and in-vivo diagnostics. Nanorobotic systems provide integrated solutions for complex medical applications. However, the nano-manipulators segment is expected to grow at the fastest CAGR during the forecast period, driven by the increasing demand for precision molecular assembly and structural manipulation at the nanoscale. The ability to deliver integrated solutions with proven clinical validation makes advanced nano-manipulator platforms highly attractive for research and pharmaceutical applications.

Based on Deployment

By deployment, the in-vitro/ex-vivo segment holds the largest market share in 2026, owing to its widespread adoption in laboratory research environments and pharmaceutical development workflows. In-vitro systems provide controlled environments for nanorobotic experimentation. The in-vivo segment is expected to witness significant growth during the forecast period, driven by the increasing demand for minimally invasive therapeutic interventions and real-time diagnostic capabilities. Advanced in-vivo nanorobotics represent an emerging frontier with tremendous potential for precision medicine applications.

Based on Technology

By technology, the magnetic actuation segment holds the largest share of the overall market in 2026, due to its proven effectiveness in enabling precise control and navigation of nanorobotic systems. Magnetic actuation provides reliable, non-invasive control mechanisms for nanoscale devices. The biohybrid propulsion segment is expected to grow at a significant CAGR during the forecast period, driven by the increasing adoption of biological propulsion systems and hybrid nanorobotic architectures. Advanced technology integration continues to enhance the capabilities and performance of nanorobotic systems.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. In 2026, North America dominates the global nanorobotics market with the largest market share, primarily attributed to massive investments in healthcare innovation and the presence of leading research institutions and pharmaceutical companies in the United States and Canada. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by aggressive government funding and the rapid adoption of advanced nanotechnologies in China, India, and Japan. Europe, Latin America, and the Middle East & Africa represent emerging markets with growing research infrastructure and increasing adoption of nanorobotic technologies.

Key Players

The key players operating in the global nanorobotics market are Calando Pharmaceuticals, Genentech (Roche), Arrowhead Research Corporation, Luna Innovations, NanoHorizon, Altair Nanotechnologies, Harris & Harris Group, and various other regional and emerging nanotechnology and healthcare innovation companies, among others.

Key Questions Answered in the Report-

  • What is the current revenue generated by the nanorobotics market globally?
  • At what rate is the global nanorobotics market demand projected to grow for the next 7-10 years?
  • What are the historical market sizes and growth rates of the global nanorobotics market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of type, deployment, technology, and application are expected to create major traction for the service providers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global nanorobotics market?
  • Who are the major players in the global nanorobotics market? What are their specific product offerings in this market?
  • What are the recent strategic developments in the global nanorobotics market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Nanorobotics Market Assessment -- by Type

  • Nano-Manipulators
  • Nanorobotic Systems

Nanorobotics Market Assessment -- by Deployment

  • In-Vivo
  • In-Vitro/Ex-Vivo

Nanorobotics Market Assessment -- by Technology

  • Magnetic Actuation
  • Biohybrid Propulsion

Nanorobotics Market Assessment -- by Application

  • Healthcare
  • Molecular Manufacturing

Nanorobotics Market Assessment -- by End-User

  • Hospitals & Clinical Centers
  • Research Institutions
  • Pharmaceutical Companies

Nanorobotics Market Assessment -- by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Scope
  • 1.3. Research Methodology
  • 1.4. Assumptions & Limitations

2. Executive Summary

3. Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
    • 3.2.4. Challenges
  • 3.3. Market Trends

4. Global Nanorobotics Market, by Type

  • 4.1. Introduction
  • 4.2. Nano-manipulators
    • 4.2.1. Atomic Force Microscopes (AFM)
    • 4.2.2. Scanning Tunneling Microscopes (STM)
    • 4.2.3. Others
  • 4.3. Nanorobotic Systems
    • 4.3.1. Bio-nanorobots
    • 4.3.2. Magnetically Guided Nanorobots
    • 4.3.3. Electromechanical Nanobots
    • 4.3.4. Others
  • 4.4. Software & Control Systems

5. Global Nanorobotics Market, by Deployment

  • 5.1. Introduction
  • 5.2. In-vivo Deployment
    • 5.2.1. Targeted Drug Delivery
    • 5.2.2. Surgical Interventions
    • 5.2.3. Diagnostic Imaging
    • 5.2.4. Tissue Engineering & Repair
    • 5.2.5. Other In-vivo Applications
  • 5.3. In-vitro/Ex-vivo Deployment
    • 5.3.1. Laboratory Research
    • 5.3.2. Drug Discovery
    • 5.3.3. Diagnostics & Testing
    • 5.3.4. Other In-vitro Applications

6. Global Nanorobotics Market, by Technology

  • 6.1. Introduction
  • 6.2. Magnetic Actuation
    • 6.2.1. Electromagnetic Field Systems
    • 6.2.2. Permanent Magnet Systems
    • 6.2.3. Hybrid Magnetic Systems
  • 6.3. Biohybrid/Biological Propulsion
    • 6.3.1. Cell-based Propulsion
    • 6.3.2. Biological Motor Systems
    • 6.3.3. Hybrid Bio-synthetic Systems
  • 6.4. Acoustic/Ultrasound Propulsion
    • 6.4.1. Ultrasonic Actuation
    • 6.4.2. Acoustic Streaming
    • 6.4.3. Resonance-based Systems
  • 6.5. Optical/Light-driven Actuation
    • 6.5.1. Photonic Propulsion
    • 6.5.2. Optogenetic Control
    • 6.5.3. Plasmonic Systems
  • 6.6. Other Technologies

7. Global Nanorobotics Market, by Application

  • 7.1. Introduction
  • 7.2. Healthcare
    • 7.2.1. Drug Delivery
    • 7.2.2. Diagnostics & Imaging
    • 7.2.3. Nanosurgery & Tissue Repair
    • 7.2.4. Dental Applications
    • 7.2.5. Other Healthcare Applications
  • 7.3. Molecular Manufacturing
  • 7.4. Research & Development
  • 7.5. Environmental Monitoring
  • 7.6. Industrial & Electronics

8. Global Nanorobotics Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinical Centers
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Academic & Research Institutes
  • 8.5. Medical Device OEMs
  • 8.6. Industrial Manufacturers
  • 8.7. Other End-Users

9. Global Nanorobotics Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. U.K.
    • 9.3.3. France
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Switzerland
    • 9.3.7. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. South Korea
    • 9.4.5. Australia & New Zealand
    • 9.4.6. Rest of Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Argentina
    • 9.5.4. Chile
    • 9.5.5. Colombia
    • 9.5.6. Rest of Latin America
  • 9.6. Middle East & Africa
    • 9.6.1. GCC Countries
      • 9.6.1.1. Saudi Arabia
      • 9.6.1.2. UAE
      • 9.6.1.3. Qatar
      • 9.6.1.4. Rest of GCC
    • 9.6.2. South Africa
    • 9.6.3. Israel
    • 9.6.4. Egypt
    • 9.6.5. Nigeria
    • 9.6.6. Rest of Middle East & Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Key Player Strategies
  • 10.3. Competitive Dashboard
    • 10.3.1. Industry Leader
    • 10.3.2. Market Differentiators
    • 10.3.3. Vanguards
    • 10.3.4. Emerging Companies
  • 10.4. Market Share Analysis, By Key Player

11. Company Profiles

  • 11.1. JEOL Ltd. (Japan)
  • 11.2. Thermo Fisher Scientific Inc. (US)
  • 11.3. Bruker Corporation (Germany)
  • 11.4. Hitachi High-Tech Corporation (Japan)
  • 11.5. ZEISS Group (Germany)
  • 11.6. Oxford Instruments (UK)
  • 11.7. Imina Technologies (Switzerland)
  • 11.8. SmarAct GmbH (Germany)
  • 11.9. Stereotaxis, Inc. (US)
  • 11.10. Ginkgo Bioworks (US)
  • 11.11. EV Group (Austria)

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization